Promethazine Hci Injection
Product Images NDC 51662-1247

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Promethazine Hci (NDC 51662-1247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

A warnings text panel for Promethazine Hydrochloride injection describing serious safety concerns such as respiratory depression in pediatric patients under 2 years and severe tissue injury including gangrene. It emphasizes the preferred intramuscular route over intravenous or subcutaneous injections, with references to detailed warnings and dosage instructions.*

FDA Label Image

Structure (Structure)

Chemical structure of promethazine hydrochloride (HCl), illustrating the molecular arrangement with two aromatic rings connected by a sulfur atom and an attached dimethylamino side chain.*

FDA Label Image

Logo (Logo)

PROMETHAZINE HCI 25 mg/mL injection carton by HF Acquisition Co. LLC, DBA HealthFirst, for intramuscular or intravenous use. The front of the box features the brand and generic names prominently, along with dosage strength, and includes manufacturer and NDC 51662-1247. The packaging is primarily white with blue and green accents.*

FDA Label Image

Vial Label (1000500 0641 0928 21 Promethazine)

Label for Promethazine HCl Injection, USP 25 mg/mL in a 1 mL vial, for intramuscular or intravenous use. The label includes storage instructions to keep the product at 20°-25°C (68°-77°F) and to protect it from light. It is labeled for prescription use only and produced by West-Ward Pharmaceuticals in Eatontown, NJ. NDC number 0641-0928-21 is shown.*

FDA Label Image

Rfid Label (51662 1247 1 Rfid Label)

A label featuring machine-readable codes and human-readable alphanumeric codes, including batch information and expiration date. It states 'SEE MANUFACTURE'S INSERT' and notes distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label includes a 2D barcode and is associated with PROMETHAZINE HCI injection distributed by the company.*

FDA Label Image

Pouch Labeling (51662124727 Promethazine Pouch Label)

Label for PROMETHAZINE HCI Injection, USP 25 mg/mL 1 mL vial. The NDC 51662-1247-2 is displayed along with lot number 12345 and an expiration date of 2001-03-01. The label specifies the drug is for deep intramuscular or intravenous use and is manufactured by HF Acquisition Co., LLC DBA HealthFirst in Mukilteo, WA. It includes a QR code and is marked RX ONLY.*

FDA Label Image

Rfid Label (51662 1247 3 Rfid)

PROMETHAZINE HCI injection label showing a white background with black text and a barcode. The label includes a National Drug Code (NDC) number, batch or lot identification, and expiration date information. It states the product is distributed by HF Acquisitions Co., LLC in Mukilteo, WA. The label advises to see the manufacturer's insert for more details.*

FDA Label Image

Case Labeling (51662124734 Promethazine Case Label)

PROMETHAZINE HCI Injection USP 25 mg/mL 1 mL vial label showing a box of 25 vials. The label includes NDC 51662-1247-3, lot number 12345, and expiration date January 1, 2030. The product is manufactured by HF Acquisition Co., LLC in Mukilteo, WA, and is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.